Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

TP53 outperforms other androgen receptor biomarkers to predict abiraterone or enzalutamide outcome in metastatic castration-resistant prostate cancer.

De Laere B, Oeyen S, Mayrhofer M, Whitington T, van Dam PJ, Van Oyen P, Ghysel C, Ampe J, Ost P, Demey W, Hoekx L, Schrijvers D, Brouwers B, Lybaert W, Everaert EG, De Maeseneer D, Strijbos M, Bols A, Fransis K, Beije N, de Kruijff IE, van Dam V, Brouwer A, Goossens D, Heyrman L, Van den Eynden GG, Rutten A, Del Favero J, Rantalainen M, Rajan P, Sleijfer S, Ullén A, Yachnin J, Grönberg H, Van Laere SJ, Lindberg J, Dirix LY.

Clin Cancer Res. 2018 Sep 12. pii: clincanres.1943.2018. doi: 10.1158/1078-0432.CCR-18-1943. [Epub ahead of print]

PMID:
30209161
2.

Effects of a six-month supervised physical exercise program on physical and cardio-metabolic profile and quality of life in patients with prostate cancer on androgen deprivation therapy: a pilot and feasibility study.

Zabegalina NS, Henderickx MMEL, Lamotte V, Segers B, Stassijns G, De Wachter S, Hoekx L.

Cent European J Urol. 2018;71(2):234-241. doi: 10.5173/ceju.2018.1652. Epub 2018 Jun 12.

3.

Circulating tumor cells and survival in abiraterone- and enzalutamide-treated patients with castration-resistant prostate cancer.

De Laere B, Oeyen S, Van Oyen P, Ghysel C, Ampe J, Ost P, Demey W, Hoekx L, Schrijvers D, Brouwers B, Lybaert W, Everaert E, Van Kerckhove P, De Maeseneer D, Strijbos M, Bols A, Fransis K, Beije N, de Kruijff I, van Dam V, Brouwer A, van Dam PJ, Van den Eynden G, Rutten A, Sleijfer S, Vandebroek J, Van Laere S, Dirix L.

Prostate. 2018 May;78(6):435-445. doi: 10.1002/pros.23488. Epub 2018 Feb 12.

PMID:
29431193
4.

Small-cell carcinoma of the penile urethra: a case report and a short review of the literature.

Altintas S, Blockx N, Huizing MT, Van den Brande J, Hoekx L, Bogers JP, Van Marck E, Vermorken JB.

Ann Oncol. 2007 Apr;18(4):801-4. Epub 2006 Dec 20. No abstract available.

PMID:
17182974
5.

Paraperitoneal indirect inguinal bladder hernia: MR demonstration.

Bernaerts A, de Beeck BO, Hoekx L, Parizel PM.

Abdom Imaging. 2005 Nov-Dec;30(6):685-8. Epub 2005 Apr 13.

PMID:
15834674
6.

Functional bladder capacity after bladder biofeedback predicts long-term outcome in children with nocturnal enuresis.

Hoekx L, Vermandel A, Wyndaele JJ.

Scand J Urol Nephrol. 2003;37(2):120-3.

PMID:
12745719
7.

[Bladder cancers].

Hoekx L.

Acta Urol Belg. 2000;68(2):34-6. Review. Dutch. No abstract available.

PMID:
11098585
8.

Biphasic sarcomatoid carcinoma (carcinosarcoma) of the renal pelvis with heterologous chondrogenic differentiation.

Vermeulen P, Hoekx L, Colpaert C, Wyndaele JJ, Van Marck E.

Virchows Arch. 2000 Aug;437(2):194-7.

PMID:
10993282
9.

Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA density.

Schatteman PH, Hoekx L, Wyndaele JJ, Jeuris W, Van Marck E.

Eur Urol. 2000 Apr;37(4):404-12.

PMID:
10765070
10.
11.

Elevated serum prostate specific antigen (PSA) related to asymptomatic prostatic inflammation.

Hoekx L, Jeuris W, Van Marck E, Wyndaele JJ.

Acta Urol Belg. 1998 Oct;66(3):1-2.

PMID:
9864868
13.

Angiokeratoma: a cause of scrotal bleeding.

Hoekx L, Wyndaele JJ.

Acta Urol Belg. 1998 Mar;66(1):27-8.

PMID:
9611356
14.

Fracture of the penis: role of ultrasonography in localizing the cavernosal tear.

Hoekx L, Wyndaele JJ.

Acta Urol Belg. 1998 Mar;66(1):23-5.

PMID:
9611355
15.

Bladder biofeedback for the treatment of refractory sensory urgency in adults.

Wyndaele JJ, Hoekx L, Vermandel A.

Eur Urol. 1997;32(4):429-32.

PMID:
9412801
16.

Carcinoma of the urachus.

Michielsen D, Hoekx L, Dewilde L, Wyndaele JJ.

Acta Urol Belg. 1995 Dec;63(4):33-5. No abstract available.

PMID:
8644553

Supplemental Content

Support Center